The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
GATA3: A Multispecific But Potentially Useful Marker in Surgical Pathology A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors
Open accessAbstract
GATA3 is a transcription factor important in the differentiation of breast epithelia, urothelia, and subsets of T lymphocytes. It has been suggested to be useful in the evaluation of carcinomas of mammary or urothelial origin or metastatic carcinomas, but its distribution in normal and neoplastic tissues is incompletely mapped. In this study, we examined normal developing and adult tissues and 2040 epithelial and 460 mesenchymal or neuroectodermal neoplasms for GATA3 expression to explore its diagnostic value in surgical pathology, using monoclonal antibody (clone L50-823) and Leica Bond automated immunohistochemistry. GATA3 was expressed in trophoblast, fetal and adult epidermis, adult mammary and some salivary gland and sweat gland ductal epithelia, urothelia, distal nephron in developing and adult tissues, some prostatic basal cells, and subsets of T lymphocytes. It was expressed stronger in fetal than in adult mesothelia and was absent in respiratory and gastrointestinal epithelia. In epithelial neoplasms, GATA3 was expressed in >90% of primary and metastatic ductal and lobular carcinomas of the breast, urothelial, and cutaneous basal cell carcinomas and trophoblastic and endodermal sinus tumors. In metastatic breast carcinomas, it was more sensitive than GCDFP. Among squamous cell carcinomas, the expression was highest in the skin (81%) and lower in cervical (33%), laryngeal (16%), and pulmonary tumors (12%). Common positivity was found in skin adnexal tumors (100%), mesothelioma (58%), salivary gland (43%), and pancreatic (37%) ductal carcinomas, whereas frequency of expression in adenocarcinomas of lung, stomach, colon, endometrium, ovary, and prostate was <10%. Chromophobe renal cell carcinoma was a unique renal tumor with frequent positivity (51%), whereas oncocytomas were positive in 17% of cases but other types only rarely. Among mesenchymal and neuroectodermal tumors, paragangliomas were usually positive, which sets these tumors apart from epithelial neuroendocrine tumors. Mesenchymal tumors were only sporadically positive, except epithelia of biphasic synovial sarcomas. GATA3 is a useful marker in the characterization of not only mammary and urothelial but also renal and germ cell tumors, mesotheliomas, and paragangliomas. The multiple specificities of GATA3 should be taken into account when using this marker to detect metastatic mammary or urothelial carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Asselin-Labat, M.-L., Sutherland, K. D., Barker, H., Thomas, R., Shackleton, M., Forrest, N. C., Hartley, L., Robb, L., Grosveld, F. G., van der Wees, J., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1530 · Cited by 840
Renal Tumors in the Birt-Hogg-Dubé Syndrome
Pavlovich, C. P., Walther, M. M., Eyler, R. A., Hewitt, S. M., Zbar, B., Linehan, W. M., & Merino, M. J. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200212000-00002 · Cited by 604
Ulbright, T. M. (2005) · Modern Pathology · doi:10.1016/s0893-3952(22)04459-3 · Cited by 592
Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2
Ralston, A., Cox, B. J., Nishioka, N., Sasaki, H., Chea, E., Rugg-Gunn, P., Guo, G., Robson, P., Draper, J. S., & Rossant, J. (2010) · Development · doi:10.1242/dev.038828 · Cited by 471
GATA-3: an unexpected regulator of cell lineage determination in skin
Kaufman, C. K., Zhou, P., Amalia Pasolli, H., Rendl, M., Bolotin, D., Lim, K.-C., Dai, X., Alegre, M.-L., & Fuchs, E. (2003) · Genes & Development · doi:10.1101/gad.1115203 · Cited by 344
GATA3 in development and cancer differentiation: Cells GATA have it!
Chou, J., Provot, S., & Werb, Z. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21943 · Cited by 304
GATA Transcription Factors and Cancer
Zheng, R., & Blobel, G. A. (2010) · Genes & Cancer · doi:10.1177/1947601911404223 · Cited by 276
Yagi, R., Zhu, J., & Paul, W. E. (2011) · International Immunology · doi:10.1093/intimm/dxr029 · Cited by 250
Higgins, J. P. T., Kaygusuz, G., Wang, L., Montgomery, K., Mason, V., Zhu, S. X., Marinelli, R. J., Presti, J. C., van de Rijn, M., & Brooks, J. D. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213438.01278.5f · Cited by 237
Home, P., Ray, S., Dutta, D., Bronshteyn, I., Larson, M., & Paul, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016840 · Cited by 227
Higher levels of GATA3 predict better survival in women with breast cancer
Yoon, N. K., Maresh, E. L., Shen, D., Elshimali, Y., Apple, S., Horvath, S., Mah, V., Bose, S., Chia, D., Chang, H. R., et al. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.06.010 · Cited by 195
GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo
Ma, G. T., Roth, M. E., Groskopf, J. C., Tsai, F.-Y., Orkin, S. H., Grosveld, F., Engel, J. D., & Linzer, D. I. H. (1997) · Development · doi:10.1242/dev.124.4.907 · Cited by 191
Expression of GATA‐3 During Lymphocyte Differentiation and Mouse Embryogenesis
Oosterwegel, M. A., Timmerman, J. J., Leiden, J. M., & Clevers, H. C. (1992) · Journal of Immunology Research · doi:10.1155/1992/27903 · Cited by 102
Morphologic features of renal oncocytoma: A light and electron microscopic study
Eble, J. N., & Hull, M. T. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80249-x · Cited by 101
Critical Role for GATA3 in Mediating Tie2 Expression and Function in Large Vessel Endothelial Cells
Song, H., Suehiro, J., Kanki, Y., Kawai, Y., Inoue, K., Daida, H., Yano, K., Ohhashi, T., Oettgen, P., Aird, W. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041145 · Cited by 91
Human Genome and Diseases: Review¶Transcription factor GATA3 and the human HDR syndrome
Esch, H. V., & Devriendt, K. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000940 · Cited by 81
Aberrant Gata-3 Expression in Human Pancreatic Cancer
Gulbinas, A., Berberat, P. O., Dambrauskas, Ž., et al. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6626.2005 · Cited by 39
Sellheyer, K., & Krahl, D. (2009) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2009.01416.x · Cited by 24
Daigeler, A., Ludger, K.-H., Stricker, I., Oliver, M., Cornelius, K., Michael, C. A., Lars, S., Goertz, O., Hans-Ulrich, S., & Lehnhardt, M. (2009) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-009-0465-0 · Cited by 22
Research works printed but not linked: 1
- Miettinen, 2012, A simple method for generating multitissue blocks without special equipment., Appl Immunohistochem Mol Morphol, 20, 410, 10.1097/PAI.0b013e318245c82f · doi:10.1097/pai.0b013e318245c82f
Cited by
Husain, Colby, Ordóñez, Allen, Attanoos, Beasley, Butnor, Chirieac, Churg, Dacic, et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0124-ra · Cited by 619
Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas
Mete, O., Asa, S. L., Gill, A. J., Kimura, N., de Krijger, R. R., & Tischler, A. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09704-6 · Cited by 424
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Yatabe, Y., Dacic, S., Borczuk, A. C., Warth, A., Russell, P. A., Lantuejoul, S., Beasley, M. B., Thunnissen, E., Pelosi, G., Rekhtman, N., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.12.005 · Cited by 365
Amin, M. B., Epstein, J. I., Ulbright, T. M., Humphrey, P. A., Egevad, L., Montironi, R., Grignon, D., Trpkov, K., Lopez-Beltran, A., Zhou, M., et al. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000254 · Cited by 314
Galateau-Salle, F., Churg, A., Roggli, V., & Travis, W. D. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.11.005 · Cited by 282
Metadata
- Authors
- Miettinen, M., McCue, P. A., Sarlomo-Rikala, M., Rys, J., Czapiewski, P., Wazny, K., Langfort, R., Waloszczyk, P., Biernat, W., Lasota, J., & Wang, Z.
- Venue
- American Journal of Surgical Pathology
- Published
- 2014-01
- Volume
- 38
- Issue
- 1
- Pages
- 13-22
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W1530437552
- Cited by
- 695
- References
- 19
- FWCI
- 28.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.